Joel Habener, Svetlana Mojsov, and Lotte Bjerre Knudsen awarded Lasker prize for pioneering work on GLP-1

• Text
• PDF

Abstract

Authors

Hossein Ardehali

Guild-based approach for mitigating information loss and distortion issues in microbiome analysis

• Text
• PDF

Abstract

Authors

Liping Zhao, Guojun Wu, Naisi Zhao

The cancer-associated secretory phenotype: a new frontier in targeted therapeutics

• Text
• PDF

Abstract

Authors

Xiaochao Tan, Guan-Yu Xiao, Priyam Banerjee, Shike Wang, Jonathan M. Kurie

Status check: next-generation sequencing for infectious-disease diagnostics

• Text
• PDF

Abstract

Next-generation sequencing (NGS) applications for the diagnostics of infectious diseases has demonstrated great potential with three distinct approaches: whole-genome sequencing (WGS), targeted NGS (tNGS), and metagenomic NGS (mNGS, also known as clinical metagenomics). These approaches provide several advantages over traditional microbiologic methods, though challenges still exist.

Authors

Kyle G. Rodino, Patricia J. Simner

Molecular and cellular mechanisms underlying the failure of mitochondrial metabolism drugs in cancer clinical trials

• Text
• PDF

Abstract

Authors

Karthik Vasan, Navdeep S. Chandel

Keeping translational research grounded in human biology

• Text
• PDF

Abstract

Authors

Saptarsi M. Haldar

Building reproducible bridges to cross the “valley of death”

• Text
• PDF

Abstract

Authors

Timothy M. Errington

Human brown fat and metabolic disease: a heated debate

• Text
• PDF

Abstract

Authors

Rana K. Gupta

Human brown adipose tissue is not enough to combat cardiometabolic diseases

• Text
• PDF

Abstract

Authors

André C. Carpentier, Denis P. Blondin

Does activating brown fat contribute to important metabolic benefits in humans? Yes!

• Text
• PDF

Abstract

Authors

Aaron M. Cypess